The Division of Asthma, Allergy & Lung Biology has three main research aims:
to elucidate the basic mechanisms that underlie the causes and effects of airway inflammation;
to understand mechanisms of anti-inflammatory drug action, and
to find ways to improve hospital care for very ill patients, including those with respiratory failure.
Our research programmes range from basic science to clinical research and include studies that will elucidate the molecular and physiological mechanisms of inflammation; research to identify and test new therapeutic approaches to treating allergies, inflammation and cancer; and clinical trials to test new allergy prevention strategies.
We have a critical research mass within the Division that creates unique synergies and offers opportunities for researchers to work closely and productively while preserving scientific independence. The close interface between our clinical and lab-based research is one of the keys to our success. We share knowledge, equipment, reagents and human materials (such as biopsy material, cell lines and clones) to maximise the potential of our resources and help translate advances in our understanding of allergic and respiratory diseases into healthcare benefits for patients as rapidly as possible.